|
|
||||||||
Genitourinary Imaging |
1 From the Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (C.M.C.T., S.G.S., D.L.B., B.J.M.); the Department of Health Care Policy, Harvard Medical School, Boston, Mass (K.H.Z., B.J.M.); and the Department of Radiology, Jefferson Medical College and Thomas Jefferson University Hospital, Philadelphia, Pa (A.B.K.). From the 1998 RSNA scientific assembly. Received February 16, 1999; revision requested April 5; revision received September 14; accepted September 24. C.M.C.T. was a GE-AUR Fellow. Supported in part by Public Health Service grant NIH-U01 CA9398-03, awarded by the National Cancer Institute, U.S. Department of Health and Human Services. Address correspondence to C.M.C.T. (e-mail: ctempany@bwh.harvard.edu).
PURPOSE: To compare ultrasonography (US), magnetic resonance (MR) imaging, and computed tomography (CT) for diagnosing and staging advanced ovarian cancer.
MATERIALS AND METHODS: US, CT, and MR imaging were performed in 280 patients. Images were read by three radiologists from each of the five hospitals. Image analysis included determination of malignancy within the peritoneum (11 sites), lymph nodes (10 sites), and hepatic parenchyma. The standard of reference was based on surgical and histopathologic findings. Statistical methods used were receiver operating characteristic (ROC) curve analysis, pairwise comparison of areas under the ROC curves (Az), analysis of sensitivity and specificity pairs, and assessment of agreement between the degree of suspicion and standard of reference.
RESULTS: There were 118 patients with malignant tumors; 73 (62%) had stage III or IV disease. Metastases were found in the peritoneum in 70 (59%), nodes in 20 (17%), and liver in seven (6%) cases. In the peritoneum, MR imaging and CT (Az = 0.96 for both) were more accurate than US (Az = 0.86), especially in the subdiaphragmatic spaces and hepatic surfaces. MR imaging and CT were more sensitive than US (95%, 92%, and 69%, respectively) for peritoneal metastases. MR imaging was more accurate than CT for detection of lymph node metastases (Az = 0.76 vs 0.57, P = .04). In the liver, the Az values for the three modalities were 0.770.94.
CONCLUSION: CT and MR imaging are equally accurate, and either modality can be used to stage advanced ovarian cancer.
Index terms: Ovary, CT, 852.12113, 852.12115 Ovary, MR, 852.121411, 852.121415, 852.12143 Ovary, neoplasms, 852.32, 852.339 Ovary, US, 852.12983, 852.12984 Receiver operating characteristic (ROC) curve
This article has been cited by other articles:
![]() |
O. Akin, E. Sala, C. S. Moskowitz, N. Ishill, R. A. Soslow, D. S. Chi, and H. Hricak Perihepatic Metastases from Ovarian Cancer: Sensitivity and Specificity of CT for the Detection of Metastases with and Those without Liver Parenchymal Invasion Radiology, August 1, 2008; 248(2): 511 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Yan, J. Sim, and D. L. Morris Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Ann. Surg. Oncol., June 1, 2007; 14(6): 1807 - 1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
M V Pakkal and M Balogun Imaging of ovarian cancer Imaging, August 1, 2006; 18(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Spencer A multidisciplinary approach to ovarian cancer at diagnosis Br. J. Radiol., October 1, 2005; 78(Special_Issue_2): S94 - S102. [Full Text] [PDF] |
||||
![]() |
R. N. Low, B. Duggan, R. M. Barone, F. Saleh, and S. Y. T. Song Treated Ovarian Cancer: MR Imaging, Laparotomy Reassessment, and Serum CA-125 Values Compared with Clinical Outcome at 1 Year Radiology, June 1, 2005; 235(3): 918 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goldberg-Zimring, B. Shalmon, K. H. Zou, H. Azhari, D. Nass, and A. Achiron Assessment of Multiple Sclerosis Lesions with Spherical Harmonics: Comparison of MR Imaging and Pathologic Findings Radiology, June 1, 2005; 235(3): 1036 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sironi, C. Messa, G. Mangili, B. Zangheri, G. Aletti, E. Garavaglia, R. Vigano, M. Picchio, G. Taccagni, A. D. Maschio, et al. Integrated FDG PET/CT in Patients with Persistent Ovarian Cancer: Correlation with Histologic Findings Radiology, November 1, 2004; 233(2): 433 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gronlund, C. Hogdall, J. Hilden, S. A. Engelholm, E. V.S. Hogdall, and H. H. Hansen Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma? J. Clin. Oncol., October 15, 2004; 22(20): 4051 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshida, T. Kurokawa, K. Kawahara, T. Tsuchida, H. Okazawa, Y. Fujibayashi, Y. Yonekura, and F. Kotsuji Incremental Benefits of FDG Positron Emission Tomography over CT Alone for the Preoperative Staging of Ovarian Cancer Am. J. Roentgenol., January 1, 2004; 182(1): 227 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Pannu, R. E. Bristow, C. Cohade, E. K. Fishman, and R. L. Wahl PET-CT in Recurrent Ovarian Cancer: Initial Observations RadioGraphics, January 1, 2004; 24(1): 209 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Woodward, K. Hosseinzadeh, and J. S. Saenger From the Archives of the AFIP: Radiologic Staging of Ovarian Carcinoma with Pathologic Correlation RadioGraphics, January 1, 2004; 24(1): 225 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Zou, J. R. Fielding, S. G. Silverman, and C. M. C. Tempany Hypothesis Testing I: Proportions Radiology, March 1, 2003; 226(3): 609 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. Coakley, P. H. Choi, C. A. Gougoutas, B. Pothuri, E. Venkatraman, D. Chi, A. Bergman, and H. Hricak Peritoneal Metastases: Detection with Spiral CT in Patients with Ovarian Cancer Radiology, May 1, 2002; 223(2): 495 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rieber, K. Nussle, I. Stohr, D. Grab, S. Fenchel, R. Kreienberg, S. N. Reske, and H.-J. Brambs Preoperative Diagnosis of Ovarian Tumors with MR Imaging: Comparison with Transvaginal Sonography, Positron Emission Tomography, and Histologic Findings Am. J. Roentgenol., July 1, 2001; 177(1): 123 - 129. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |